Company intelligence / Profile preview

Wingderm Electro-Optics

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Wingderm’s medical aesthetic devices, including FDA-cleared non-ablative fractional laser systems, are commercialized globally for skin resurfacing, hair removal, and skin rejuvenation. Devices are recognized for safety and effectiveness with over 25,000 units installed in 80+ countries.

Therapeutic areas: GastroenterologyDermatology
Modalities: DeviceLaser therapy deviceEnergy-based deviceNon-invasive device
Industry: Therapeutic Medical Devices

Partnerships

Thai distributor (for Asian market)Swiss Clinitech Sàrl

Beyond the preview

Go deeper on Wingderm Electro-Optics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wingderm Electro-Optics.

Explore the full profile